Application 022536
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INDOMETHACIN | INDOMETHACIN | INJECTABLE;INJECTION | EQ 1MG BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022536-001 | INDOMETHACIN | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022536-001 | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022536-001 | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N022536-001 | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022536-001 | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N022536-001 | INDOMETHACIN | EQ 1MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2010-03-17 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | ec482425-358c-4500-8f5d-79c1379c1fa8 | 2026-01-19 | Warnings, Adverse reactions | 022536 NDA022536 63323-659 |
| Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | 30e38747-c553-4e2d-bc23-634e1dd90b8d | 2023-06-16 | Warnings, Adverse reactions | 022536 NDA022536 63323-659 |
| Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | dd5caa3f-3c09-4034-bf43-2df80c61c07b | 2023-06-01 | Warnings, Adverse reactions | 022536 NDA022536 63323-659 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-659 | Indomethacin | INDOMETHACIN | Fresenius Kabi USA, LLC | NDA | Current |